CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 401 enrolled
Drug / intervention
Topical Antibiotic Product +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03199911
NCT03199911Phase 4Completed
CompareCT.gov

The Role of Topical Antibiotic Prophylaxis in Eyelid Surgery

University of California, San Francisco·interventional·Posted Jun 27, 2017·Updated Jul 21, 2020

In Brief

A Phase 4 clinical trial evaluating Topical Antibiotic Product and Topical Non-Antibiotic Ointment for Antibiotic Side Effect and 8 related conditions. Completed, enrolled 401 participants across 1 site.

Detailed Summary

The investigators propose a prospective randomized control trial testing the hypothesis that routine topical antibiotic prophylaxis does not significantly reduce the rate of infection after eyelid surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAntibiotic Side Effect, Eyelid; Wound, Eyelid Diseases, Surgical Wound Infection, Surgical Wound, Recent, Surgical Incision, Skin Cancer Face, Antibiotic Allergy, Surgical Site Infection
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedJun 27, 2017
Enrollment StartOct 2, 2017
Primary CompletionNov 14, 2019
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.0 years ago

Interventions

Topical Antibiotic Productdrug

Topical antibiotic ointment will be erythromycin or bacitracin. If the patient cannot obtain either (e.g. lack of availability at the pharmacy), bacitracin polymyxin will be prescribed. Allergy to all 3 study drugs means that a patient will be excluded from the study.

Topical Non-Antibiotic Ointmentdrug

Mineral oil/petrolatum-based artificial tear ointment.